Injection could permanently lower cholesterol by changing DNA
New Scientist - 06-Feb-2017People born with natural mutations that disable a specific gene have a lower risk of heart disease
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Entrepreneur in Residence (EiR) at Hevolution Foundation, CEO at Mayr BioMedTech Consulting
Previously, he was the Chief Technology Officer for GE Healthcare Life Sciences, overseeing R&D investment, research programmes and business growth strategy. Prior to this he held senior leadership positions at Novartis, Astra Zeneca and Bayer. He also holds a position as a Visiting Scientist/Guest Professor at the ETHZ, the Swiss Federal Institute of Technology at Zurich/Switzerland.
Visit website: https://www.biomedtech-consulting.com/
See alsoDetails last updated 23-Jul-2020
People born with natural mutations that disable a specific gene have a lower risk of heart disease